0001646343-19-000007.txt : 20190814 0001646343-19-000007.hdr.sgml : 20190814 20190814160859 ACCESSION NUMBER: 0001646343-19-000007 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20190630 FILED AS OF DATE: 20190814 DATE AS OF CHANGE: 20190814 EFFECTIVENESS DATE: 20190814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NEXTHERA CAPITAL LP CENTRAL INDEX KEY: 0001646343 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-17280 FILM NUMBER: 191026394 BUSINESS ADDRESS: STREET 1: 900 THIRD AVENUE STREET 2: SUITE 201-2 CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: (212) 213-7033 MAIL ADDRESS: STREET 1: 900 THIRD AVENUE STREET 2: SUITE 201-2 CITY: NEW YORK STATE: NY ZIP: 10022 13F-HR 1 primary_doc.xml 13F-HR LIVE false true false 0001646343 XXXXXXXX 06-30-2019 06-30-2019 NEXTHERA CAPITAL LP
900 THIRD AVENUE SUITE 201-2 NEW YORK NY 10022
13F HOLDINGS REPORT 028-17280 N
Daniel Malek Managing Member/CEO 6462137030 Daniel Malek New York NY 08-14-2019 0 23 120064 false
INFORMATION TABLE 2 nexthera13f_q22019.xml AbbVie Inc COM 00287Y109 3831 52681 SH SOLE 52681 0 0 Allergan PLC SHS G0177J108 560 3347 SH SOLE 3347 0 0 Amarin Corp PLC SPONS ADR NEW 023111206 4465 230295 SH SOLE 230295 0 0 AnaptysBio Inc COM 032724106 679 12026 SH SOLE 12026 0 0 Ascendis Pharma A/S SPONSORED ADR 04351P101 6940 60266 SH SOLE 60266 0 0 Biohaven Pharmaceutical Holdin COM G11196105 3773 86165 SH SOLE 86165 0 0 Audentes Therapeutics Inc COM 05070R104 11131 294013 SH SOLE 294013 0 0 Coherus Biosciences Inc COM 19249H103 6991 316316 SH SOLE 316316 0 0 Dermira Inc COM 24983L104 1320 138102 SH SOLE 138102 0 0 Global Blood Therapeutics Inc COM 37890U108 7485 142305 SH SOLE 142305 0 0 Gilead Sciences Inc COM 375558103 1263 18697 SH SOLE 18697 0 0 Intercept Pharmaceuticals Inc COM 45845P108 12130 152441 SH SOLE 152441 0 0 Immunomedics Inc COM 452907108 7270 524140 SH SOLE 524140 0 0 Insmed Inc COM PAR $.01 457669307 12051 470741 SH SOLE 470741 0 0 Intra-Cellular Therapies Inc COM 46116X101 1865 143665 SH SOLE 143665 0 0 Madrigal Pharmaceuticals Inc COM 558868105 1616 15423 SH SOLE 15423 0 0 Mylan NV SHS EURO N59465109 1953 102560 SH SOLE 102560 0 0 Neurocrine Biosciences Inc COM 64125C109 7800 92380 SH SOLE 92380 0 0 Pacira BioSciences Inc COM 695127100 6484 149086 SH SOLE 149086 0 0 uniQure NV SHS N90064101 4680 59883 SH SOLE 59883 0 0 Regeneron Pharmaceuticals Inc COM 75886F107 1774 5668 SH SOLE 5668 0 0 Sarepta Therapeutics Inc COM 803607100 7646 50317 SH SOLE 50317 0 0 UroGen Pharma Ltd COM M96088105 6357 176866 SH SOLE 176866 0 0